Two Sigma Investments’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-16,387
| Closed | -$645K | – | 3390 |
|
|
2023
Q2 | $645K | Buy |
+16,387
| New | +$578K | ﹤0.01% | 2204 |
|
|
2022
Q3 | – | Sell |
-1,386,542
| Closed | -$13.3M | – | 2956 |
|
|
2022
Q2 | $13.3M | Buy |
1,386,542
+456,631
| +49% | +$5.73M | 0.04% | 426 |
|
|
2022
Q1 | $15.7M | Sell |
929,911
-358,005
| -28% | -$5.29M | 0.05% | 457 |
|
|
2021
Q4 | $21.5M | Sell |
1,287,916
-238,310
| -16% | -$3.91M | 0.05% | 451 |
|
|
2021
Q3 | $24.8M | Buy |
1,526,226
+1,230,217
| +416% | +$13.4M | 0.06% | 388 |
|
|
2021
Q2 | $1.87M | Buy |
296,009
+108,665
| +58% | +$701K | ﹤0.01% | 1926 |
|
|
2021
Q1 | $1.16M | Buy |
187,344
+176,753
| +1,669% | +$1.07M | ﹤0.01% | 2176 |
|
|
2020
Q4 | $73K | Buy |
+10,591
| New | +$67.8K | ﹤0.01% | 3230 |
|
|
2020
Q3 | – | Sell |
-33,470
| Closed | -$171K | – | 3687 |
|
|
2020
Q2 | $171K | Sell |
33,470
-162,785
| -83% | -$678K | ﹤0.01% | 2690 |
|
|
2020
Q1 | $675K | Buy |
+196,255
| New | +$1.15M | 0.01% | 1721 |
|
|
2019
Q4 | – | Sell |
-118,306
| Closed | -$133K | – | 4079 |
|
|
2019
Q3 | $133K | Sell |
118,306
-21,033
| -15% | -$24.5K | ﹤0.01% | 3270 |
|
|
2019
Q2 | $181K | Sell |
139,339
-93,486
| -40% | -$128K | ﹤0.01% | 3115 |
|
|
2019
Q1 | $328K | Buy |
232,825
+59,691
| +34% | +$83.5K | ﹤0.01% | 2542 |
|
|
2018
Q4 | $208K | Buy |
173,134
+90,396
| +109% | +$175K | ﹤0.01% | 2686 |
|
|
2018
Q3 | $195K | Sell |
82,738
-68,397
| -45% | -$170K | ﹤0.01% | 3020 |
|
|
2018
Q2 | $413K | Buy |
+151,135
| New | +$417K | ﹤0.01% | 2755 |
|
|
2018
Q1 | – | Sell |
-117,527
| Closed | -$367K | – | 3622 |
|
|
2017
Q4 | $367K | Buy |
+117,527
| New | +$330K | ﹤0.01% | 2634 |
|
|
2017
Q3 | – | Sell |
-23,570
| Closed | -$60K | – | 3314 |
|
|
2017
Q2 | $60K | Sell |
23,570
-306,227
| -93% | -$834K | ﹤0.01% | 2883 |
|
|
2017
Q1 | $1.21M | Buy |
329,797
+221,967
| +206% | +$938K | ﹤0.01% | 1796 |
|
|
2016
Q4 | $521K | Buy |
+107,830
| New | +$3.2M | ﹤0.01% | 2487 |
|
|
2015
Q2 | – | Sell |
-93,907
| Closed | -$4.37M | – | 3172 |
|
|
2015
Q1 | $4.37M | Buy |
93,907
+82,433
| +718% | +$4.28M | 0.02% | 782 |
|
|
2014
Q4 | $515K | Buy |
+11,474
| New | +$482K | ﹤0.01% | 1709 |
|
|
2014
Q3 | – | Sell |
-7,714
| Closed | -$326K | – | 2122 |
|
|
2014
Q2 | $326K | Sell |
7,714
-2,686
| -26% | -$98.6K | ﹤0.01% | 1797 |
|
|
2014
Q1 | $372K | Buy |
+10,400
| New | +$351K | ﹤0.01% | 1593 |
|
Two Sigma Investments's ISEE Position: Q3 2023 in Review
Two Sigma Investments sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 16,387 shares — an estimated $645K sold.
Two Sigma Investments first reported a position in ISEE in Q1 2014 and held it in 24 quarters. The position peaked at $24.8M in Q3 2021. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.
- Two Sigma Investments reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Two Sigma Investments sold 16,387 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $645K.
- Two Sigma Investments first reported a position in IVERIC bio, Inc. Common Stock in Q1 2014 and held it in 24 quarters.
- Two Sigma Investments's IVERIC bio, Inc. Common Stock position peaked at $24.8M in Q3 2021.
- 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.
Based on Two Sigma Investments's 13F filing for Q3 2023, filed 14 Nov 2023.